Insulet
PODD
#1055
Rank
C$29.43 B
Marketcap
C$418.13
Share price
1.99%
Change (1 day)
11.48%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2025 (TTM): C$0.51 Billion

According to Insulet's latest financial reports the company's current earnings are C$2.52 Billion. In 2024 the company made an earning of C$0.47 Billion, an increase over its 2023 earnings that were of C$0.34 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) C$0.51 B8.02%
2024 C$0.47 B36.72%
2023 C$0.34 B481.9%
2022 C$59.65 M-45.24%
2021 C$0.10 B43.35%
2020 C$75.98 M18.51%
2019 C$64.12 M41.16%
2018 C$45.42 M-711.95%
2017 -C$7.43 Million-56.85%
2016 -C$17.21 Million-79.31%
2015 -C$83.17 Million63.85%
2014 -C$50.76 Million31.04%
2013 -C$38.74 Million-21.96%
2012 -C$49.64 Million
2010 -C$47.35 Million-42.38%
2009 -C$82.17 Million-33.56%
2008 -C$0.13 Billion65.93%
2007 -C$74.53 Million209.75%
2006 -C$24.07 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ICU Medical
ICUI
C$0.17 B-65.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-C$0.29 Billion-156.35%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
C$1.35 B 168.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$44.84 B 8,807.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$11.26 B 2,137.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
C$8.85 B 1,659.69%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
C$31.14 B 6,087.41%๐Ÿ‡บ๐Ÿ‡ธ USA